Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

especially in indoor spaces These respiratory droplets and aerosols are created when an infected person: COVID-19 can also spread by touching something that has the virus on it, then touching your ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

Clesrovimab led to significant reductions in RSV-associated MALRI, hospitalizations, and was comparable in safety to palivizumab.

The FDA approved RSV vaccine Abrysvo, which protects against lung infections, for high-risk adults as young as 18 with ...

The North Bay Parry Sound District Health Unit announced the availability of a new preventive medication for Respiratory Syncytial Virus for newborns and eligible infants up to 24 months of age. The ...

The North Bay Parry Sound District Health Unit announced the availability of a new preventive medication for Respiratory Syncytial Virus for newborns and eligible infants up to 24 months of age.

Respiratory virus data included in the interactive data application is up-to-date as of November 2, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.